EUVIMEDEUVIMED entdecken
Kohortenstudie

MRI Response Pattern of Breast Invasive Micropapillary Carcinoma After Neoadjuvant Chemotherapy: A Matched Cohort Study With Invasive Breast Cancer of no Special Type

Dan Gao, Zeng Yongjia, Yingying Gao, Liujin Zeng, Meichan Yang, Zhouyang Lian, Chunling Liu

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.05.014 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Dan Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Thyroid Disease Center, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Magnetic Resonance Imaging, Carcinoma, Papillary. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Neoadjuvant chemotherapy (NAC) is more widely used to treat localized invasive breast cancer. Invasive micropapillary carcinoma (IMPC) is considered more aggressive than invasive breast cancer of no special type (IBC- NST), as an independent histological type of invasive breast cancer (IBC). However, it is rarely reported about the response of IMPC to NAC. Therefore, we compared the NAC response of IMPC and IBCNST groups to provide an evidence-based foundation for precise clinical management of breast IMPC about NAC. METHODS: The retrospective study included 127 patients with pathologically confirmed IMPC or IBCNST patients from December 2016 to April 2021, and divided them into 3 group. The MRI feature and Clinicopathologic data of all the patients were assessed before and after NAC. One-way ANOVA test and Krukal-Wallis test were used for statistical analysis. RESULTS: After NAC, IMPC patients showed less changes in lesion size, EER, shrinking rate and ADC values compared to the IBC patients (P < .05). In IPMC patients, 7.7% of lesions achieved a pathologic complete response (pCR), 61.5% with partial response (PR), 2.6% with progressive disease (PD) and 28.2% with stable disease (SD). Moreover, the lesions response to NAC was not significantly different between IMPC group and IBC2 group. CONCLUSIONS: Most patients with IMPC can obtain the same PR rates after NAC as IBCNST. Breast-conserving treatment (BCT) can be applied in More patients with IMPC. Therefore, we hold the opinion that NAC can be strongly suggested to be used for IMPC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapyMagnetic Resonance ImagingCarcinoma, PapillaryAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesMiddle AgedAdultAgedChemotherapy, AdjuvantNeoplasm InvasivenessBreastTreatment OutcomeFollow-Up Studies

Stichwörter der Autor:innen

Invasive breast cancer of no special typeInvasive micropapillary carcinomaMRINeoadjuvant chemotherapy

Autor:innen und Institutionen

  • Breast and Thyroid Disease Center, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China.
  • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong, China.
  • Department of Radiology, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong, China.
  • Department of Radiology, HeYuan People's Hospital, Guangdong, China.
  • Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong, China.
  • Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong, China. Electronic address: liuchunling@gdph.org.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gao, D., Yongjia, Z., Gao, Y., Zeng, L., Yang, M., Lian, Z., & Liu, C. (2025). MRI Response Pattern of Breast Invasive Micropapillary Carcinoma After Neoadjuvant Chemotherapy: A Matched Cohort Study With Invasive Breast Cancer of no Special Type. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.05.014

Vancouver

Gao D, Yongjia Z, Gao Y, Zeng L, Yang M, Lian Z, et al. MRI Response Pattern of Breast Invasive Micropapillary Carcinoma After Neoadjuvant Chemotherapy: A Matched Cohort Study With Invasive Breast Cancer of no Special Type. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.05.014

BibTeX
@article{Gao2025,
  author = {Gao, Dan and Yongjia, Zeng and Gao, Yingying and Zeng, Liujin and Yang, Meichan and Lian, Zhouyang and Liu, Chunling},
  title = {MRI Response Pattern of Breast Invasive Micropapillary Carcinoma After Neoadjuvant Chemotherapy: A Matched Cohort Study With Invasive Breast Cancer of no Special Type},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.05.014}
}
Kostenlos starten →